Mercaptopurine and haemoglobin decreased Patient Reports February 12, 2012

Mercaptopurine Side Effects Report #5328758-8
Mercaptopurine side effect was reported by a Pharmacist from UNITED STATES on May 16, 2007. Female patient, 72 years of age, weighting 149.9 lb, was diagnosed with polymyositis and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, white blood cell count decreased. Mercaptopurine dosage: unknown. During the same period patient was treated with LOPRESSOR, NOVOLIN R, CYMBALTA, ASPIRIN, CLONIDINE, PLAVIX, DIGOXIN, FOLIC ACID. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #5699085-4
Mercaptopurine side effect was reported by a Health Professional from UNITED STATES on May 17, 2007. Male patient, 48 years of age, was diagnosed with crohn's disease  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, white blood cell count decreased. Mercaptopurine dosage: 100 MG DAILY,PO. During the same period patient was treated with PENTASA, QUESTRAN. Patient recovered.

Mercaptopurine Side Effects Report #5146228-7
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, weighting 172.4 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cholelithiasis, diarrhoea, haemoglobin decreased, hepatomegaly, pain , pain of skin, platelet count decreased, prothrombin time prolonged. Mercaptopurine dosage: 11449 MG. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, VINCRISTINE SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #5378396-6
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Male patient, weighting 31.75 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood glucose decreased, blood insulin decreased, blood pressure diastolic decreased, gait disturbance, haemoglobin decreased, heart rate increased, hyperhidrosis, hypothermia . Mercaptopurine dosage: 2800 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.